Treatment of Acute UTI with Visible Hematuria

Initial Diagnostic Approach

• The European Urology guidelines recommend obtaining urinalysis and urine culture with sensitivity testing before starting antibiotics to guide therapy in older patients, as resistant organisms and atypical presentations are more common 1, 2, 3
• Visible hematuria is a UTI symptom that warrants antibiotic treatment, not a contraindication, according to the European Urology guidelines 4, 5, 6
• Assess for systemic symptoms, including fever, rigors, costovertebral angle tenderness, or delirium, which would indicate complicated infection requiring different management 7, 4

Empiric Antibiotic Selection

• The American Urological Association recommends first-line agents, including nitrofurantoin, trimethoprim-sulfamethoxazole, or fosfomycin, chosen based on local antibiogram 1, 2, 3
• Nitrofurantoin is preferred due to low resistance rates and minimal collateral damage to protective microbiota 8
• Fosfomycin is a single-dose option with broad coverage and age-independent resistance patterns 7, 4

Treatment Duration

• The standard treatment duration is 7 days for acute cystitis in patients with recurrent UTIs or complicating factors 2
• Shorter 3-day courses are not appropriate for patients over 80 years old, as age constitutes a complicating factor 7, 4

Critical Considerations for This Age Group

• Antimicrobial treatment in older patients generally follows the same principles as younger adults, unless specific complicating factors exist 7, 4
• Fluoroquinolones should be avoided as first-line therapy due to FDA warnings about disabling adverse effects 8
• Asymptomatic bacteriuria should not be treated, even in elderly patients 1, 2

When to Modify Initial Approach

• Parenteral antibiotics should be considered if the patient has a high fever with rigors, is unable to tolerate oral medications, or has a culture that returns resistant to all oral options 1, 2, 7
• Therapy should be adjusted once culture results are available, with a narrow spectrum based on sensitivities, and continued for the full 7-day course even if symptoms resolve earlier 1, 2, 3, 7, 9

Common Pitfalls to Avoid

• Cystoscopy or upper tract imaging should not be obtained routinely for visible hematuria in the setting of acute UTI 3
• Fluoroquinolones should not be used empirically due to significant collateral damage and FDA warnings 8
• Treatment should not be extended beyond 7 days without clear indication, as longer courses promote resistance without improving outcomes 1, 2